Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.21
Bid: 3.62
Ask: 4.80
Change: 0.00 (0.00%)
Spread: 1.18 (32.597%)
Open: 4.21
High: 0.00
Low: 0.00
Prev. Close: 4.21
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proteome reaches milestone in launch of proteomics service

Wed, 03rd Aug 2022 15:33

(Sharecast News) - Proteome Sciences has completed its next milestone towards the launch of 'single cell proteomics' services, it announced on Wednesday, dubbed 'SysQuant SCP'.

The AIM-traded firm said it had installed a 'cellenONE' platform to allow the semi-automated preparation of up to 2,700 cells per week.

It expected that most commercial projects would require analysis of between 500 and 1,000 cells using 'TMTpro' multiplexing, meaning it would now be able to perform one or two such studies each week.

Working with such small samples was described by Proteome as "challenging", and beyond the means of many academic and industrial research groups.

The company said it believed its employees' experience as inventors and manufacturers of TMT and TMTpro reagents gave it "unique insights" into their use in such a "complex" setting.

Following initial experiments, the firm said it expected coverage of between 1,000 and 1,500 proteins per cell.

It said it was anticipating completion of the platform and process validation in the third quarter, and to then launch the dedicated multiplex SysQuant SCP services before the end of the year.

That would complement the expansion of its mass spectrometer platforms late last year, and would establish Proteome Sciences as "the premier provider" of single cell proteomics, the board said.

"It is clear that the demand for a standardised service is growing rapidly," said chief scientific officer Ian Pike.

"The use of TMTpro reagents is greatly enhancing coverage in studies of hundreds of individual cells and provides the throughput necessary for large studies needed in pharmaceutical research.

"By isolating and labelling each cell with TMTpro tags and then mixing to make a more concentrated sample on the cellenONE platform, we can explore the true diversity of functional biology in every disease, with the potential to identify new drug targets and diagnostic biomarkers."

Dr Pike said the system provided the level of throughput required for Proteome's initial plans to launch a SysQuant SCP service, and would be scalable to rapidly increase capacity amid a growing market opportunity.

"This is a major step in the process and we have further exciting developments for single cell proteomics planned for the future."

At 1051 BST, shares in Proteome Sciences were uo 12.59% at 4.17p.

Reporting by Josh White at Sharecast.com.

More News
30 Nov 2010 13:34

Small caps round-up: Tinci, Nasstar, 600 Group...

Environmental engineering group Tinci Holdings jumped after it announced contracts worth 45.4m Chinese Renminbi (£4.34m) to provide paper desulfurisation technology to two subsidiaries of the Dongguan Jiulong Paper Group. These projects are expected to start shortly and last for about six months. N

Read more
13 Jul 2010 09:30

UK SMALLCAP ROUNDUP: African Minerals Gets $1.5B For Tonkolili

Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps AFRICAN MINERALS LTD. (AMI.LN), an iron ore miner focused on Sierra Leone, Tuesday said it agreed a $1.5 billion investment in its Tonkolili project from

Read more
13 Jul 2010 08:03

Proteome Sciences Develops Two Alzheimer's Tests

LONDON (Dow Jones)--Diagnostics company Proteome Sciences PLC (PRM.LN) Tuesday said it developed two tests focused on aspects of Alzheimer's disease. The company, which specializes in identifying proteins that could be hallmarks of disease, said one of the tests measures levels of nine proteins

Read more
18 Jun 2010 07:25

Proteome Sciences: German Court To Hear Sanofi Case End July

LONDON (Dow Jones)--Proteome Sciences PLC (PRM.LN), a life sciences company delivering content for personalised medicine, said Friday it has received notification from the Civil Division of the Higher Regional Court in Frankfurt that the Court now intends to take witness evidence at the end of July

Read more
6 Jul 2009 07:17

Proteome seals Alzheimer's tie-up

Proteome Sciences has signed an exclusive license agreement with Millipore Corp to develop new products aimed at helping advance the study of Alzheimer's disease. The disease identification specialist says Millipore will develop Luminex bead-based multiplex immunoassays to measure Proteome Sciences

Read more
18 Jun 2009 08:08

Proteome extends loan facility

Revenue rose strongly at disease identification specialist Proteome Sciences last year but cash inflows have fallen short of expectations. Revenue in 2008 rose to £0.85m from £0.27m in 2007 while loss before tax narrowed to £4.8m from £5.5m the year before. Cash in hand at the end of 2008 stood at

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.